Upstream Bio revenue was $3.32M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $1.0M, up 54.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, UPB annual revenue was $2.9M, with 20.4% growth year-over-year.
UPB past revenue growth
How has UPB's revenue growth performed historically?
On Invalid Date, Upstream Bio (NASDAQ: UPB) reported Q1 2026 revenue of $1.03 million up 82.69% year over year. In the same quarter last year, Upstream Bio's revenue was $566.00 thousand.
What was Upstream Bio's revenue in 2025?
Upstream Bio's annual revenue for the twelve months ending Dec 31, 2025 was $2.85 million, a 20.42% increase year over year.
How much does Upstream Bio make in a day?
Based on Upstream Bio annual revenue for the past three years, UPB makes an average of $6,944.29 per day.
What was Upstream Bio's annual revenue growth in the past year?
As of Q2 2026, Upstream Bio's revenue has grown 44.69% year over year. This is 216.05 percentage points lower than the US Biotechnology industry revenue growth rate of 260.73%. Upstream Bio's revenue in the past year totaled $3.32 million.
How much does Upstream Bio make in a year?
Upstream Bio's revenue by year for the past three years is:
Upstream Bio's revenue for the twelve months ending Dec 31, 2025 was $2.85 million, a 20.42% increase year over year.
Upstream Bio's annual revenue for Dec 31, 2024 was $2.37 million, a 0.42% decrease from 2023.
Upstream Bio's annual revenue for 2023 was $2.38 million, a 96.37% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.